X
API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
0
Other Certificates
Other Suppliers
USA (Orange Book)
Europe
Canada
Australia
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
53
PharmaCompass offers a list of Raltegravir Potassium API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Raltegravir Potassium manufacturer or Raltegravir Potassium supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Raltegravir Potassium manufacturer or Raltegravir Potassium supplier.
PharmaCompass also assists you with knowing the Raltegravir Potassium API Price utilized in the formulation of products. Raltegravir Potassium API Price is not always fixed or binding as the Raltegravir Potassium Price is obtained through a variety of data sources. The Raltegravir Potassium Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Raltegravir Potassium Salt manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Raltegravir Potassium Salt, including repackagers and relabelers. The FDA regulates Raltegravir Potassium Salt manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Raltegravir Potassium Salt API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Raltegravir Potassium Salt manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Raltegravir Potassium Salt supplier is an individual or a company that provides Raltegravir Potassium Salt active pharmaceutical ingredient (API) or Raltegravir Potassium Salt finished formulations upon request. The Raltegravir Potassium Salt suppliers may include Raltegravir Potassium Salt API manufacturers, exporters, distributors and traders.
click here to find a list of Raltegravir Potassium Salt suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Raltegravir Potassium Salt DMF (Drug Master File) is a document detailing the whole manufacturing process of Raltegravir Potassium Salt active pharmaceutical ingredient (API) in detail. Different forms of Raltegravir Potassium Salt DMFs exist exist since differing nations have different regulations, such as Raltegravir Potassium Salt USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Raltegravir Potassium Salt DMF submitted to regulatory agencies in the US is known as a USDMF. Raltegravir Potassium Salt USDMF includes data on Raltegravir Potassium Salt's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Raltegravir Potassium Salt USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Raltegravir Potassium Salt suppliers with USDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Raltegravir Potassium Salt Drug Master File in Korea (Raltegravir Potassium Salt KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Raltegravir Potassium Salt. The MFDS reviews the Raltegravir Potassium Salt KDMF as part of the drug registration process and uses the information provided in the Raltegravir Potassium Salt KDMF to evaluate the safety and efficacy of the drug.
After submitting a Raltegravir Potassium Salt KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Raltegravir Potassium Salt API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Raltegravir Potassium Salt suppliers with KDMF on PharmaCompass.
A Raltegravir Potassium Salt CEP of the European Pharmacopoeia monograph is often referred to as a Raltegravir Potassium Salt Certificate of Suitability (COS). The purpose of a Raltegravir Potassium Salt CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Raltegravir Potassium Salt EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Raltegravir Potassium Salt to their clients by showing that a Raltegravir Potassium Salt CEP has been issued for it. The manufacturer submits a Raltegravir Potassium Salt CEP (COS) as part of the market authorization procedure, and it takes on the role of a Raltegravir Potassium Salt CEP holder for the record. Additionally, the data presented in the Raltegravir Potassium Salt CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Raltegravir Potassium Salt DMF.
A Raltegravir Potassium Salt CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Raltegravir Potassium Salt CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Raltegravir Potassium Salt suppliers with CEP (COS) on PharmaCompass.
A Raltegravir Potassium Salt written confirmation (Raltegravir Potassium Salt WC) is an official document issued by a regulatory agency to a Raltegravir Potassium Salt manufacturer, verifying that the manufacturing facility of a Raltegravir Potassium Salt active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Raltegravir Potassium Salt APIs or Raltegravir Potassium Salt finished pharmaceutical products to another nation, regulatory agencies frequently require a Raltegravir Potassium Salt WC (written confirmation) as part of the regulatory process.
click here to find a list of Raltegravir Potassium Salt suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Raltegravir Potassium Salt as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Raltegravir Potassium Salt API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Raltegravir Potassium Salt as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Raltegravir Potassium Salt and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Raltegravir Potassium Salt NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Raltegravir Potassium Salt suppliers with NDC on PharmaCompass.
Raltegravir Potassium Salt Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Raltegravir Potassium Salt GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Raltegravir Potassium Salt GMP manufacturer or Raltegravir Potassium Salt GMP API supplier for your needs.
A Raltegravir Potassium Salt CoA (Certificate of Analysis) is a formal document that attests to Raltegravir Potassium Salt's compliance with Raltegravir Potassium Salt specifications and serves as a tool for batch-level quality control.
Raltegravir Potassium Salt CoA mostly includes findings from lab analyses of a specific batch. For each Raltegravir Potassium Salt CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Raltegravir Potassium Salt may be tested according to a variety of international standards, such as European Pharmacopoeia (Raltegravir Potassium Salt EP), Raltegravir Potassium Salt JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Raltegravir Potassium Salt USP).
Market Place
